BNGO Logo.png
Study Finds the Combination of Optical Genome Mapping and Short-Read Sequencing Provides a Comprehensive Genome Analysis for Lung Cancer Samples and Enables the Discovery of New Biomarkers
September 16, 2021 08:00 ET | Bionano Genomics
SAN DIEGO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a study finding the combination of optical genome mapping (OGM) and short-read next-generation...
BNGO Logo.png
NuProbe Global Adopts Bionano’s Saphyr® System to Develop Products in Reproductive Health and Oncology Applications
September 07, 2021 08:00 ET | Bionano Genomics
SAN DIEGO and SHANGHAI, China, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that NuProbe Global, a global molecular diagnostics company based in Shanghai,...
BNGO Logo.png
Bionano Genomics Announces ESHG Lineup Featuring 11 Customer Presentations of OGM Data Spanning Three Major Clinical Research Areas of Application from 10 Institutions and Six Countries
August 26, 2021 08:00 ET | Bionano Genomics
SAN DIEGO, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the European Society of Human Genetics (ESHG) conference lineup featuring 11 customer presentations...
BNGO Logo.png
Bionano Genomics Reports Second Quarter 2021 Financial Results and Highlights Recent Business Progress
August 04, 2021 16:05 ET | Bionano Genomics
226% year-over-year total revenue increase driven by growth in the Saphyr installed baseAll 2021 milestones on trackStrong balance sheet with $333 million in cash as of June 30, 2021Conference call...
BNGO Logo.png
Bionano Genomics to Report Second Quarter 2021 Financial Results and Host a Conference Call and Webcast on August 4, 2021
July 28, 2021 16:30 ET | Bionano Genomics
SAN DIEGO, July 28, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, August 4, 2021 at 4:30 p.m....
BNGO Logo.png
Bionano Genomics Announces a Record Number of Optical Genome Mapping Presentations Scheduled to Appear at the Annual Cancer Genomics Consortium Meeting from August 1st - 4th, 2021
July 27, 2021 08:00 ET | Bionano Genomics
SAN DIEGO, July 27, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a record number of optical genome mapping (OGM) presentations scheduled to appear at the annual...
BNGO Logo.png
Bionano’s Optical Genome Mapping for Acute Lymphoblastic Leukemia Subjects at the University Hospitals Leuven, Belgium, Has Faster Turnaround Time, Higher Success Rates and Lower Cost per Sample Compared to Traditional Methods
July 19, 2021 08:00 ET | Bionano Genomics
SAN DIEGO, July 19, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announces a summary of the results obtained by the University Hospitals Leuven, Belgium with optical genome mapping...
BNGO Logo.png
Bionano’s Optical Genome Mapping Reveals New Insights and Prognostic Capabilities Compared to Traditional Cytogenetics Techniques in Several Leukemia Clinical Research Studies Presented at the ECA
July 14, 2021 08:00 ET | Bionano Genomics
SAN DIEGO, July 14, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced optical genome mapping (OGM) reveals new insights and prognostic capabilities compared to...
BNGO Logo.png
Bionano’s Optical Genome Mapping Extensively Featured at the 2021 European Cytogenomics Conference as a Superior Solution for Genomic Analysis in Leukemia and Genetic Disease Compared to Traditional Techniques
July 13, 2021 08:00 ET | Bionano Genomics
SAN DIEGO, July 13, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that optical genome mapping (OGM) was extensively featured across a wide range of talks and posters...
BNGO Logo.png
Bionano Genomics Announces Back-to-Back Publications in the American Journal of Human Genetics that Compare Optical Genome Mapping to Traditional Methods for Structural Variant Analysis in Inherited Genetic Disease and Hematological Malignancies
July 07, 2021 11:00 ET | Bionano Genomics
SAN DIEGO, July 07, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that two peer-reviewed studies from world renowned scientists and clinicians from prestigious...